{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:26:34Z","timestamp":1794345994462,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bbi.2010.08.003","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T05:05:20Z","timestamp":1281503120000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":840,"title":["Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome"],"prefix":"10.1016","volume":"25","author":[{"given":"Paul","family":"Ashwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Krakowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irva","family":"Hertz-Picciotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Pessah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Van de Water","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2010.08.003_b0245","unstructured":"American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, fourth edition. American Psychiatric Association Publishing Inc., Washington DC, USA."},{"key":"10.1016\/j.bbi.2010.08.003_b0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1023\/B:JOCI.0000010427.05143.bb","article-title":"Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology","volume":"23","author":"Ashwood","year":"2003","journal-title":"J. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2010.08.003_b0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s10875-004-6241-6","article-title":"Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10","volume":"24","author":"Ashwood","year":"2004","journal-title":"J. Clin. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2005.12.007","article-title":"Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms","volume":"173","author":"Ashwood","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jneuroim.2008.07.006","article-title":"Decreased transforming growth factor \u03b21 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes","volume":"204","author":"Ashwood","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10803-006-0353-1","article-title":"Plasma leptin levels are elevated in autism: association with early onset phenotype?","volume":"38","author":"Ashwood","year":"2008","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.bbi.2010.08.003_b0035","unstructured":"Ashwood, P., Nguyen, D.V., Hessl, D., Hagerman, R.J., Tassone, F. in press. Plasma cytokine profiles in Fragile X subjects: Is there a role for cytokines in the pathogenesis? Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.bbi.2010.08.003_b0040","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nn755","article-title":"TNF\u03b1 contributes to the death of NGF-dependent neurons during development","volume":"4","author":"Barker","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.bbi.2010.08.003_b0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.plefa.2006.02.001","article-title":"Fatty acid composition of red blood cell phospholipids in children with autism","volume":"74","author":"Bu","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.bbi.2010.08.003_b0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/glia.20616","article-title":"In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia","volume":"56","author":"Cacci","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2010.08.003_b0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1196\/annals.1381.010","article-title":"Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder","volume":"1107","author":"Cabanlit","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bbi.2010.08.003_b0060","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2005.07.004","article-title":"Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau\u2013Kleffner syndrome, and epilepsy","volume":"59","author":"Connolly","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2010.08.003_b0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.mp.4001943","article-title":"A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins","volume":"12","author":"Corbett","year":"2007","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048665","article-title":"Activation of the inflammatory response system in autism","volume":"45","author":"Croonenberghs","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbi.2010.08.003_b0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3844\/ajbbsp.2008.114.120","article-title":"Detection of IL-17 and IL-23 in plasma samples of children with autism","volume":"4","author":"Enstrom","year":"2008","journal-title":"Am. J. Biochem. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbi.2010.08.003_b0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3844\/ajbbsp.2008.121.129","article-title":"Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism","volume":"4","author":"Enstrom","year":"2008","journal-title":"Am. J. Biochem. Biotechnol."},{"key":"10.1016\/j.bbi.2010.08.003_b0085","first-page":"463","article-title":"Autoimmunity in autism","volume":"10","author":"Enstrom","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.bbi.2010.08.003_b0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbi.2008.12.005","article-title":"Increased IgG4 levels in children with autism disorder","volume":"23","author":"Enstrom","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbi.2008.08.001","article-title":"Altered gene expression and function of peripheral blood natural killer cells in children with autism","volume":"23","author":"Enstrom","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2009.08.001","article-title":"Differential monocyte responses to TLR ligands in children with autism spectrum disorders","volume":"24","author":"Enstrom","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2010.08.003_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/stem.170127","article-title":"Leukemia inhibitory factor, interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury","volume":"17","author":"Gadient","year":"1999","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.bbi.2010.08.003_b0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.nbd.2008.01.012","article-title":"Immune transcriptome alterations in the temporal cortex of subjects with autism","volume":"30","author":"Garbett","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2004.10.008","article-title":"Maternal poly I:C exposure during pregnancy regulates TNF\u03b1, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat","volume":"159","author":"Gilmore","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.bbi.2010.08.003_b0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1542\/peds.2007-3604","article-title":"Macrophage migration inhibitory factor and autism spectrum disorders","volume":"122","author":"Grigorenko","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0165-5728(98)00021-6","article-title":"Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism","volume":"85","author":"Gupta","year":"1998","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ambp.2007.08.006","article-title":"Regression in autism: prevalence and associated factors in the CHARGE Study","author":"Hansen","year":"2008","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.bbi.2010.08.003_b0135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1289\/ehp.8483","article-title":"The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism","volume":"114","author":"Hertz-Picciotto","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbi.2010.08.003_b0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1073858402008003012","article-title":"Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity","volume":"8","author":"Juttler","year":"2002","journal-title":"Neuroscientist"},{"issue":"2","key":"10.1016\/j.bbi.2010.08.003_b0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000084164","article-title":"Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention","volume":"51","author":"Jyonouchi","year":"2005","journal-title":"Neuropsychobiology"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2010.08.003_b0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-3233(08)60437-4","article-title":"Cytokines in brain development and function","volume":"52","author":"Mehler","year":"1998","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.bbi.2010.08.003_b0160","unstructured":"MMWR Surveill. Summ, 2009. Prevalence of autism spectrum disorders \u2013 Autism and Developmental Disabilities Monitoring Network, United States, 2006. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC). 58 (10): 1\u201320."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jneuroim.2005.11.007","article-title":"Elevated cytokine levels in children with autism spectrum disorder","volume":"172","author":"Molloy","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.bbi.2010.08.003_b0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0301-0082(98)00045-8","article-title":"The role of tumour necrosis factor, interleukin 6, interferon-\u03b3 and inducible nitric oxide synthase in the development and pathology of the nervous system","volume":"56","author":"Munoz-Fernandez","year":"1998","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pnpbp.2006.08.020","article-title":"Decreased serum levels of transforming growth factor-\u03b21 in patients with autism","volume":"31","author":"Okada","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2009.09.005","article-title":"Decreased cellular IL-23 production in children with autism spectrum disorders","volume":"216","author":"Onore","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bbi.2010.08.003_b0185","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.biopsych.2009.06.020","article-title":"An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children","volume":"66","author":"Saresella","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","article-title":"Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring","volume":"23","author":"Shi","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2010.08.003_b0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0090-1229(05)80015-7","article-title":"Changes of soluble interleukin-2, interleukin-2 receptor, T 8 antigen, and interleukin-1 in the serum of autistic children","volume":"61","author":"Singh","year":"1991","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-5728(96)00014-8","article-title":"Plasma increase of interleukin-12 and interferon-\u03b3. Pathological significance in autism","volume":"66","author":"Singh","year":"1996","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0205","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneuroim.2004.03.015","article-title":"Autoantibody repertoires to brain tissue in autism nuclear families","volume":"152","author":"Silva","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.bbi.2010.08.003_b0210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biopsych.2003.09.001","article-title":"High nitric oxide production in autistic disorder: a possible role for interferon-\u03b3","volume":"55","author":"Sweeten","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2010.08.003_b0215","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0006-3223(88)90012-1","article-title":"Antibrain antibodies in infantile autism","volume":"23","author":"Todd","year":"1988","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2010.08.003_b0220","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.biopsych.2006.12.018","article-title":"Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth","volume":"62","author":"Tsuchiya","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2010.08.003_b0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0165-5728(02)00180-7","article-title":"Antibodies to neuron-specific antigens in children with autism: Possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A","volume":"129","author":"Vojdani","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbi.2010.08.003_b0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2008.07.007","article-title":"Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders","volume":"23","author":"Wills","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2010.08.003_b0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2005.03.014","article-title":"Cerebrospinal fluid and serum markers of inflammation in autism","volume":"33","author":"Zimmerman","year":"2005","journal-title":"Pediatr. Neurol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159110004289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159110004289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:24:06Z","timestamp":1760167446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159110004289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0889159110004289"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2010.08.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5459957.8923054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.5459957.5423055","asserted-by":"object"}]},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2010.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}